GMPharm
Enterprise number 0781862362 · Active (000 Normale toestand)
GMPharm is a besloten vennootschap registered in Perwez, Belgium, incorporated on 11 Feb 2022. Its registered activity is speur- en ontwikkelingswerk op biotechnologisch gebied.
Company details
- Enterprise number
- 0781862362 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 11 Feb 2022 (5 years)
- Registered address
- 1360 Perwez
- Province
- Walloon Brabant
- Activity
- 72110 Speur- en ontwikkelingswerk op biotechnologisch gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Walloon Brabant
- "CLINICAL & QUALITY SUPPORT" Villers-la-Ville
- ABAXYS THERAPEUTICS Villers-la-Ville
- ACADEMIC MEDICAL INTERDISCIPLINARY RESEARCH FOUNDATION - RECHERCHE ACADEMIQUE MEDICALE INTERDISCIPLINAIRE FOUNDATION Lasne
- ADBDL Médecine et Sciences médicales Wavre
- ALANINE Lasne
- ALLSIGHTSAFRICA Orp-Jauche
- ANSERS Perwez
- AQYLA BioVenture Builder Wavre
- ARSALIS Genappe
- ART - OS Waterloo
- ARTLINOW Lasne
- ARXIOS Genappe
Questions about GMPharm
What is the enterprise number of GMPharm?
GMPharm is registered under enterprise number 0781862362 in the official register of Belgium. View it at the official register.
Is GMPharm still active?
Yes. GMPharm is registered as active (status: 000 Normale toestand).
Has GMPharm gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for GMPharm in the official data.
When was GMPharm founded?
GMPharm was incorporated on 11 Feb 2022.
Where is GMPharm registered?
GMPharm's registered address is in 1360 Perwez (Walloon Brabant), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.